Skip to main content
. 2017 Dec 8;9(2):2866–2875. doi: 10.18632/oncotarget.23165

Figure 4. Overall survival in patients with different risk factors in surgery group and non-surgery group.

Figure 4

(AD) represent OS for patients with parametrical invasion, pelvic lymph node metastases, residual disease and tumor diameter > 4 cm, respectively.